fbpx

Day

januar 5, 2015
2,000L Demonstration Batch Completed at Lonza, Houston FacilitySAN DIEGO, Jan. 5, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that it has conducted initial scale up of its viral manufacturing process for MYDICAR (AAV1/SERCA2a) to commercial scale.
SAN DIEGO, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene therapy, today announced that it has been added to the NASDAQ Biotechnology Index, through the annual update that will become effective prior to market open on Monday, December 22, 2014.The NASDAQ...

Nyheder

Hjernestimulation skal lindre symptomer ved Parkinsons sygdom
25. januar 2021
Minihjerner skal kaste lys over nervesygdomme
25. januar 2021
Mekanismer bag skizofreni
25. januar 2021

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge